APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+. 1996

R Sulkava, and K Kainulainen, and A Verkkoniemi, and L Niinistö, and E Sobel, and Z Davanipour, and T Polvikoski, and M Haltia, and K Kontula
Department of Community Health and General Practice, University of Kuopio, Finland.

Apolipoprotein E genotyping was carried out in a stratified random sample of 52 patients with Alzheimer's disease, 48 patients with vascular or mixed dementia, and 49 nondemented controls in a population-based study of people aged 85 and older (the Vantaa 85+ Study). Our results indicate that the apolipoprotein E epsilon 4 allele is associated with approximately a twofold increase in clinically diagnosed Alzheimer's disease in this very old general population aged 85+. When combined with previous studies, our data also suggest that the association is decreasing with age. In contrast, there appears to be no relation between apolipoprotein E alleles and clinically diagnosed vascular dementia.

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D015140 Dementia, Vascular An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44) Arteriosclerotic Dementia,Binswanger Disease,Encephalopathy, Binswanger,Leukoencephalopathy, Subcortical,Subcortical Arteriosclerotic Encephalopathy,Vascular Dementia,Acute Onset Vascular Dementia,Arteriosclerotic Encephalopathy, Subcortical,Binswanger Encephalopathy,Binswanger's Disease,Chronic Progressive Subcortical Encephalopathy,Encephalopathy, Binswanger's,Encephalopathy, Chronic Progressive Subcortical,Encephalopathy, Subcortical Arteriosclerotic,Encephalopathy, Subcortical, Chronic Progressive,Subcortical Encephalopathy, Chronic Progressive,Subcortical Leukoencephalopathy,Subcortical Vascular Dementia,Vascular Dementia, Acute Onset,Arteriosclerotic Dementias,Arteriosclerotic Encephalopathies, Subcortical,Binswanger's Encephalopathy,Binswangers Disease,Dementia, Arteriosclerotic,Dementia, Subcortical Vascular,Dementias, Arteriosclerotic,Dementias, Subcortical Vascular,Dementias, Vascular,Disease, Binswanger,Disease, Binswanger's,Encephalopathies, Subcortical Arteriosclerotic,Encephalopathy, Binswangers,Leukoencephalopathies, Subcortical,Subcortical Arteriosclerotic Encephalopathies,Subcortical Leukoencephalopathies,Subcortical Vascular Dementias,Vascular Dementia, Subcortical,Vascular Dementias,Vascular Dementias, Subcortical

Related Publications

R Sulkava, and K Kainulainen, and A Verkkoniemi, and L Niinistö, and E Sobel, and Z Davanipour, and T Polvikoski, and M Haltia, and K Kontula
September 1997, Annals of the New York Academy of Sciences,
R Sulkava, and K Kainulainen, and A Verkkoniemi, and L Niinistö, and E Sobel, and Z Davanipour, and T Polvikoski, and M Haltia, and K Kontula
January 2010, Neurobiology of aging,
R Sulkava, and K Kainulainen, and A Verkkoniemi, and L Niinistö, and E Sobel, and Z Davanipour, and T Polvikoski, and M Haltia, and K Kontula
April 1998, Neurology,
R Sulkava, and K Kainulainen, and A Verkkoniemi, and L Niinistö, and E Sobel, and Z Davanipour, and T Polvikoski, and M Haltia, and K Kontula
January 2020, Frontiers in aging neuroscience,
R Sulkava, and K Kainulainen, and A Verkkoniemi, and L Niinistö, and E Sobel, and Z Davanipour, and T Polvikoski, and M Haltia, and K Kontula
November 2002, Journal of the neurological sciences,
R Sulkava, and K Kainulainen, and A Verkkoniemi, and L Niinistö, and E Sobel, and Z Davanipour, and T Polvikoski, and M Haltia, and K Kontula
January 1998, Journal of neurology, neurosurgery, and psychiatry,
R Sulkava, and K Kainulainen, and A Verkkoniemi, and L Niinistö, and E Sobel, and Z Davanipour, and T Polvikoski, and M Haltia, and K Kontula
February 2001, Psychiatry and clinical neurosciences,
R Sulkava, and K Kainulainen, and A Verkkoniemi, and L Niinistö, and E Sobel, and Z Davanipour, and T Polvikoski, and M Haltia, and K Kontula
April 2014, Nihon rinsho. Japanese journal of clinical medicine,
R Sulkava, and K Kainulainen, and A Verkkoniemi, and L Niinistö, and E Sobel, and Z Davanipour, and T Polvikoski, and M Haltia, and K Kontula
October 2000, Neuroscience letters,
R Sulkava, and K Kainulainen, and A Verkkoniemi, and L Niinistö, and E Sobel, and Z Davanipour, and T Polvikoski, and M Haltia, and K Kontula
March 2012, Journal of neural transmission (Vienna, Austria : 1996),
Copied contents to your clipboard!